Beximco Pharma Ltd has disclosed its unaudited earnings for the second Quarter (July-September’ 2020).

As per the disclosure,(Octobor-December’ 2020) its earnings per share (EPS) was Tk 2.54 for against one year Tk 1.89

(July,20-December’ 2020) for the earnings per share (EPS) was Tk 4.95 for against one year Tk 3.83  compared to the same period of previous year.

Its net asset value (NAV) per share was tk 76.45

Sunbd/NJ